Our Casp11–/– mice showed significant inhibition of NAFLD (Figure 1), implying that caspase-11 promotes cholesterol biosynthesis and fatty acid β-oxidation. The gene discussed is SCAF11; the disease is metabolic dysfunction-associated steatotic liver disease.